Checking on the cell cycle

Journal of Cellular Biochemistry

Volumn , Issue SUPPL. 30/31, 1998, Pages 50-54

  Edward Mercer, W ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Cancer; Cell cycle regulation; p21; p53; Wip21

Indexed keywords

ARTICLE; CELL CYCLE PHASE; CELL DIVISION; DNA SYNTHESIS; GENE EXPRESSION REGULATION; GROWTH REGULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SCHIZOSACCHAROMYCES POMBE; TUMOR SUPPRESSOR GENE; ANIMAL; CELL CYCLE; GENETICS; PHYSIOLOGY; REVIEW;

SACCHAROMYCES CEREVISIAE; SCHIZOSACCHAROMYCES POMBE;

ANIMALS; CELL CYCLE; CELL DIVISION; GENES, P53; HUMANS;

EID: 0032429749     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Agarwal ML, Agarwal A, Taylor WR, Stark GR (1995): p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 92:8493-8497.
2. Brash DE, Rudolph JA, Simon JA, Lin A, Mckenna GJ, Baden HP, Halperin AJ, Ponten J (1991): A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinomas. Proc Natl Acad Sci USA 88: 10124-10128.
3. Desai D, Wessling HC, Fisher RP, Morgan DO (1995): Effects of phosphorylation by CAK on cyclin binding CDC2 and CDK2. Mol Cell Biol 15:345-350.
4. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993): WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
5. El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang AY, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW, Vogelstein B (1994): WAF1/ CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54:1169-1174.
6. Fearon ER, Vogelstein B (1990): Agenetic model for colorectal tumorigenesis. Cell 61:759-767.
7. Fiscella M, Zhang H-L, Fan S, Sakaguchi K, Shen S, Mercer WE, Vande Woude GF, O'Conner PM, Appella E (1997): Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation, in a p53-dependent manner. Proc Natl Acad Sci USA 94:6048-6053.
8. Harper JW, Admi GR, Wei N, Keyomars K, Elledrige SJ (1993): The p21 Cdk-inhibitory protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
9. Harris CC, Hollstein M (1993): Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 393:1918-1327.
10. Hartwell LH, Kastan MB (1994): Cell cycle control and cancer. Science 266:1821-1828.
11. Hermeking H, Lengauer C, Polyak K, He T-C, Zhang L, Thiagalingam S, Kinzer KW, Vogelstein B (1997): 14-3-3σ is a p53-regulated inhibitor of G2/M progression. Mol Cell 1:3-11.
12. Hollstein M, Sidransky D, Vogelstein B, Harris C (1991): p53 mutations in human cancers. Science 253:49-53.
13. Hunter T, Pines J (1994): Cyclins and cancer. II. Cyclin D and cdk inhibitors come of age. Cell 79:573-583.
14. Hupp TR, Lane DP: Allosteric activation of latent p53 tetramers. Curr Biol 4:865-874.
15. Kastan MB (1997): Molecular biology of cancer: The cell cycle. In De Vita VT Jr, Hellman S, Rosenberg SA (eds): "Cancer: Principles and Practice of Oncology." 5th ed. Philadelphia: Lippincott-Raven, pp 121-134.
16. Levine AJ (1997): p53, the cellular gatekeeper for growth and division. Cell 88:323-331.
17. MacLachlan TK, Sang N, Giordano A (1995): Cyclins, cyclindependent kinase and cdk inhibitors: Implications in cell cycle control and cancer. Grit Rev Eukaryot Gene Expr 5:127-156.
18. Mercer WE (1993): Biochemical control of the cell cycle. In Moossas AR, Schimptt SC (eds): "Comprehensive Textbook of Oncology Updates." Vol 1. Philadelphia: Williams & Wilkins, pp 1-12.